Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2077
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG NO:BG0122011-
dc.date.accessioned2026-01-14T08:14:18Z-
dc.date.available2026-01-14T08:14:18Z-
dc.date.issued2025-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2077-
dc.description.abstractIntroduction: Distinguishing between alcoholic liver disease (ALD) and non alcoholic fatty liver disease (NAFLD) poses a significant clinical challenge due to overlapping histopathological features, particularly when patient history regarding alcohol consumption is unreliable. The Alcoholic Liver Disease/Non Alcoholic Fatty Liver Disease Index (ANI) has emerged as a promising non invasive biomarker to differentiate between these conditions, potentially obviating the need for liver biopsy. This study aimed to evaluate the diagnostic accuracy of the ANI scoring system in distinguishing ALD from NAFLD in a tertiary care setting.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectAlcoholic liver disease; Non alcoholic fatty liver disease; ANI score; Non invasive biomarker; Liver fibrosis; Transaminases; SGOT/SGPT ratio; Fibroscan; Diagnostic accuracyen_US
dc.titleDiagnostic value of alcoholic liver disease / non alcoholic fatty liver disease index ( ani ) in differentiating alcoholic liver disease and non alcoholic fatty liver disease one year based observational study in teritary care centreen_US
dc.typeDissertationsen_US
Appears in Collections:General Medicine MD

Files in This Item:
File Description SizeFormat 
BG0122011.pdf3.07 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.